PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Psychiatric University Clinics Basel, University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland. Electronic address: maximilian.meyer@upk.ch.\', \'Psychiatric University Clinics Basel, University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland.\', \'Psychiatric University Clinics Basel, University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland; Division of Substance Use Disorders, Psychiatric Clinic, Psychiatric Services of Thurgovia, Seeblickstrasse 3, CH-8596 Münsterlingen, Switzerland.\', \'Psychiatric University Clinics Basel, University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland; Department for Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Lenggstrasse 3, 8008 Zurich, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0955-3959(21)00466-710.1016/j.drugpo.2021.103548
?:hasPublicationType
?:journal
  • The International journal on drug policy
is ?:pmid of
?:pmid
?:pmid
  • 34920218
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic-Is an update of legal restrictions warranted?
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all